News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Alexion Pharmaceuticals Inc. (ALXN) Reports Second Quarter 2013 Results



7/25/2013 7:48:23 AM

Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Second Quarter 2013 Financial Highlights:

•Q2 2013 net product sales increased 35 percent to $370.1 million, compared to $274.7 million in Q2 2012.

•Q2 2013 GAAP net income increased 164 percent to $95.9 million, or $0.48 per share, compared to Q2 2012 GAAP net income of $36.3 million, or $0.18 per share. Q2 2012 GAAP net income included $21.8 million of tax expense related to structuring of the Enobia acquisition.

Help employers find you! Check out all the jobs and post your resume.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES